These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3402526)

  • 1. Transsynovial kinetics of piroxicam in patients with rheumatoid arthritis.
    Kurowski M; Dunky A
    Eur J Clin Pharmacol; 1988; 34(4):401-6. PubMed ID: 3402526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transsynovial distribution and protein binding of pirazolac in patients with rheumatoid arthritis.
    Kurowski M; Dunky A; Geddawi M
    Eur J Clin Pharmacol; 1986; 31(3):307-11. PubMed ID: 3792428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of age on piroxicam disposition in rheumatoid arthritis.
    Blocka KL; Richardson CJ; Wallace SM; Ross SG; Verbeeck RK
    J Rheumatol; 1988; 15(5):757-63. PubMed ID: 3172091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diminished superoxide production of synovial fluid neutrophils in patients with rheumatoid arthritis following piroxicam treatment.
    Biemond P; Han H; Swaak AJ; Koster JF
    Scand J Rheumatol; 1990; 19(2):151-6. PubMed ID: 2159656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of piroxicam to synovial fluid and plasma proteins in patients with rheumatoid arthritis.
    Trnavská Z; Trnavský K; Zlnay D
    Eur J Clin Pharmacol; 1984; 26(4):457-61. PubMed ID: 6734706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-prostaglandin and anti-inflammatory short-term efficacy of piroxicam in rheumatoid arthritis.
    Strusberg A; Montrull H; Meirovich CI
    Eur J Rheumatol Inflamm; 1983; 6(1):41-5. PubMed ID: 6574910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synovial tissue levels in comparison with synovial fluid and serum concentrations following a single daily administration of 20 mg piroxicam (Felden)].
    Thabe H; Fassbender HG; Laufen H; Gierend M
    Z Rheumatol; 1986; 45(5):271-6. PubMed ID: 3811635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of piroxicam therapy on granulocyte function and granulocyte elastase concentration in peripheral blood and synovial fluid of rheumatoid arthritis patients.
    Montecucco C; Mazzone A; Pasotti D; Caporali R; Longhi M; Casilli D; Ricevuti G; Fratino P; Ruffilli MP
    Inflammation; 1989 Apr; 13(2):211-20. PubMed ID: 2547713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of lumiracoxib in plasma and synovial fluid.
    Scott G; Rordorf C; Reynolds C; Kalbag J; Looby M; Milosavljev S; Weaver M; Huff JP; Ruff DA
    Clin Pharmacokinet; 2004; 43(7):467-78. PubMed ID: 15139795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated plasma and synovial fluid pharmacokinetics of tenoxicam in patients with rheumatoid arthritis and osteoarthritis: factors determining the synovial fluid/plasma distribution ratio.
    Hinderling PH; Hartmann D; Crevoisier C; Moser U; Heizmann P
    Ther Drug Monit; 1988; 10(3):250-60. PubMed ID: 3262939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma and synovial fluid concentrations of piroxicam during prolonged treatment with piroxicam pivalic ester.
    Chérié Lignière G; Montagnani G; Alberici M; Acerbi D
    Arzneimittelforschung; 1987 May; 37(5):560-3. PubMed ID: 3619977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synovial fluid and plasma kinetics of repeat dose sustained action tiaprofenic acid in patients with rheumatoid arthritis.
    Nichol FE; Samanta A; Rose CM
    Drugs; 1988; 35 Suppl 1():46-51. PubMed ID: 3359945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transsynovial kinetics of indoprofen in patients with rheumatoid arthritis and cyclooxygenase-inhibition in vitro.
    Kurowski M; Schiemann A; Siebler D
    Int J Clin Pharmacol Res; 1988; 8(4):287-93. PubMed ID: 3141302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy, safety, and pharmacokinetic profiles of extended-release ketoprofen and piroxicam in patients with rheumatoid arthritis.
    Caldwell JR
    Clin Ther; 1994; 16(2):222-35. PubMed ID: 8062318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piroxicam concentrations in plasma and synovial fluid after a single dose of piroxicam-beta-cyclodextrin.
    Bannwart B; Bertin P; Péhourcq F; Schaeverbeke T; Gillet P; Lefrançois G; Trèves R; Dehais J; Netter P; Gaucher A
    Int J Clin Pharmacol Ther; 2001 Jan; 39(1):33-6. PubMed ID: 11204935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics of total and unbound concentrations of tenoxicam in synovial fluid and plasma.
    Day RO; Williams KM; Graham S; Handel M
    Arthritis Rheum; 1991 Jun; 34(6):751-60. PubMed ID: 2053921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transsynovial distribution of oxaprozin.
    Kurowski M; Thabe H
    Agents Actions; 1989 Jun; 27(3-4):458-60. PubMed ID: 2801338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and laboratory changes produced by piroxicam in rheumatoid arthritis.
    De Zubiria RC; Charria A; Lobo Guerrero D
    Eur J Rheumatol Inflamm; 1983; 6(1):56-62. PubMed ID: 6861814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of piroxicam: new aspects.
    Fenner H
    Eur J Rheumatol Inflamm; 1987; 8(1):42-8. PubMed ID: 3622592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ibuprofen kinetics in plasma and synovial fluid of arthritic patients.
    Gallo JM; Gall EP; Gillespie WR; Albert KS; Perrier D
    J Clin Pharmacol; 1986 Jan; 26(1):65-70. PubMed ID: 3950052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.